The fund remains Guardant’s largest holder with more than 20 million shares, according to data compiled by Bloomberg.
NEW YORK: SoftBank Vision Fund shed 4.9 million shares of high-flying Guardant Health Inc as the fund’s other investments faced valuation and regulatory turmoil.
The Guardant shares were sold for US$77 a piece on Wednesday, according to a Friday filing. That’s below the cancer-testing company’s record-high close of US$110.30 in August, but still a hefty hike from last year’s US$19 initial public offering price.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
